Search results
Results from the WOW.Com Content Network
Price Action: VRTX stock is down 13.4% at $387.37 at last check Thursday. Read Next: Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $228.08, marking a -0.23% move from the previous day.
Vertex Pharmaceuticals' (NASDAQ:VRTX) stock is up by 5.4% over the past three months. Given its impressive performance...
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
Image source: The Motley Fool. Vertex Pharmaceuticals (NASDAQ: VRTX) Q3 2024 Earnings Call Nov 04, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
In 2012 ivacaftor was designated as an orphan drug, identifying cystic fibrosis as affecting fewer than 200,000 people in the United States.On 31 January 2012, Vertex gained FDA approval [22] of the first drug, Kalydeco, [23] to treat the underlying cause of cystic fibrosis rather than the symptoms, in patients 6 years or older who have the G551D gene mutation.
Sometimes a potential drug or treatment may seem like a failure, but can still be salvaged for researchers' use. That is the case with Vertex Pharmaceuticals Inc.'s (VRTX) VX-864 for Alpha-1 ...
VRTX may refer to: Versatile Real-Time ... Vertex Pharmaceuticals (Nasdaq stock symbol) PowerEdge VRTX, a computer hardware product line from Dell This page was last ...